ONO 8713
Latest Information Update: 02 Dec 2003
At a glance
- Originator Ono Pharmaceutical
- Class Cinnamates
- Mechanism of Action Prostaglandin E1 antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Diabetes insipidus; Genitourinary disorders
Most Recent Events
- 02 Dec 2003 No development reported - Preclinical for Diabetes insipidus in Japan (unspecified route)
- 02 Dec 2003 No development reported - Preclinical for Genitourinary disorders in Japan (unspecified route)
- 28 Mar 2001 New profile